Serve Robotics Expands Into Indoor Healthcare Robots With Diligent Deal

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

• Serve Robotics (NasdaqCM:SERV) has agreed to acquire Diligent Robotics, an AI-powered indoor robotics company focused on hospital environments.

• The deal expands Serve Robotics’ reach from sidewalk delivery robots into indoor autonomous services across healthcare facilities.

• The acquisition gives Serve Robotics immediate exposure to new commercial use cases for service robots beyond outdoor delivery.

Serve Robotics, known for its sidewalk delivery robots, is now stepping into indoor settings through the acquisition of Diligent Robotics. Diligent brings experience deploying autonomous robots in hospitals, which can complement Serve’s existing focus on last mile delivery. For investors watching NasdaqCM:SERV, this move connects the company to broader demand for automation in both logistics and healthcare.

This deal introduces Serve to additional revenue opportunities tied to hospital workflows and other indoor services, not just restaurant or retail delivery. As service robotics adoption widens across sectors, the combined business could explore multiple models, from delivery to in-facility support, across different customer types and contract structures.

Stay updated on the most important news stories for Serve Robotics by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Serve Robotics.

How Serve Robotics stacks up against its biggest competitors

• ✅ Price vs Analyst Target: At US$12.26, the share price sits about 35% below the US$18.86 analyst target.

• ⚖️ Simply Wall St Valuation: DCF valuation status is unknown, so there is no clear under or overvaluation signal here.

• ✅ Recent Momentum: The 30 day return is roughly 25%, which shows strong short term momentum.

Check out Simply Wall St’s in depth valuation analysis for Serve Robotics.

• 📊 The Diligent Robotics deal broadens Serve Robotics from sidewalk delivery into hospital and indoor use cases. This could change how investors think about its end markets.

• 📊 Watch how management integrates Diligent, any new contracts in healthcare, and whether revenue starts to reflect these additional indoor opportunities.

• ⚠️ The company is loss making with a net income margin of about 41% loss and has recently diluted shareholders, so funding and execution risk remain important to track.

For the full picture including more risks and rewards, check out the complete Serve Robotics analysis.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SERV.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]